Skip to main content
Clinical Trials/CTRI/2021/08/035488
CTRI/2021/08/035488CompletedPhase 3

CLINICAL EVALUATION OF SIDDHA HERBAL FORMULATION NELLI MULLI ILAGAM IN THE TREATMENT OF PITHA PAANDU (IRON DEFICIENCY ANAEMIA) - CLINICAL STUDY

ational Institute of Siddha0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients with appropriate symptoms like pallor of skin, excessive of thirst, fatigue, blurred vision, giddiness, chest tightness, breathlessness, pungent or bitter taste, angular stomatitis, glossitis, cheilosis
  • Hb level less than normal range,
  • For male: 9-11gms/d1
  • For female: 8-10gms /dl
  • Abnormal peripheral smear study ââ?¬â?? Microcytic Hypochromic Anaemia
  • Patient willing to undergo blood investigation.

Exclusion Criteria

  • Presence of any associated severe systemic illness like cancer, AIDS
  • Chronic Kidney Disease
  • Diabetes Mellitus
  • Pregnant women
  • Inherited defects like Sickle cell anaemia, Thalassemia, Aplastic anaemia
  • Patients not willing to give blood sample

Investigators

Similar Trials